QUADRANT CAPITAL GROUP LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q3 2018. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$2,374
-65.0%
148
-49.5%
0.00%
-100.0%
Q2 2023$6,792
+28.2%
293
+28.5%
0.00%0.0%
Q1 2023$5,297
-36.1%
228
-60.1%
0.00%0.0%
Q4 2022$8,285
+107.1%
571
+205.3%
0.00%0.0%
Q3 2022$4,000
+33.3%
1870.0%0.00%
Q2 2022$3,000
+50.0%
187
+101.1%
0.00%
Q1 2022$2,000
-33.3%
930.0%0.00%
Q4 2021$3,0000.0%930.0%0.00%
Q3 2021$3,000
-90.6%
93
-96.7%
0.00%
-100.0%
Q2 2020$32,000
+14.3%
2,824
+168.4%
0.01%
+133.3%
Q4 2019$28,000
-3.4%
1,0520.0%0.00%
-25.0%
Q3 2019$29,000
+3.6%
1,0520.0%0.00%0.0%
Q2 2019$28,000
+1300.0%
1,052
+995.8%
0.00%
Q1 2019$2,000
+100.0%
96
+74.5%
0.00%
Q4 2018$1,000
-50.0%
550.0%0.00%
-100.0%
Q3 2018$2,0000.0%550.0%0.00%0.0%
Q2 2018$2,000
+100.0%
550.0%0.00%
Q1 2018$1,0000.0%550.0%0.00%
Q4 2017$1,0000.0%550.0%0.00%
Q3 2017$1,000550.0%0.00%
Q2 2017$0
-100.0%
550.0%0.00%
Q1 2017$1,000
-80.0%
55
-63.6%
0.00%
-100.0%
Q1 2016$5,0001510.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Camber Capital Management LP 2,750,000$75,900,0002.61%
PFM Health Sciences, LP 2,025,681$55,909,0001.90%
Tieton Capital Management, LLC 118,456$3,269,0001.83%
Altium Capital Management LP 190,000$5,244,0001.45%
DISCIPLINED GROWTH INVESTORS INC /MN 1,846,490$50,963,0001.03%
EARNEST PARTNERS LLC 6,316,365$174,332,0001.01%
Glenview Capital Management 1,679,747$46,361,0000.99%
Zebra Capital Management LLC 14,209$392,0000.63%
AIMZ Investment Advisors, LLC 44,185$1,220,0000.48%
Phocas Financial Corp. 132,101$3,646,0000.46%
View complete list of MYRIAD GENETICS INC shareholders